- Home
- ZDGE vs VERU Comparison
ZDGE vs VERU Comparison
Compare ZDGE & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZDGE | VERU |
|---|---|---|
| Founded | 2008 | 1971 |
| Country | United States | United States |
| Employees | 81 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 39.8M |
| IPO Year | N/A | 1990 |
Fundamental Metrics
Financial Performance| Metric | ZDGE | VERU |
|---|---|---|
| Price | $3.27 | $2.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 2.7M | 164.8K |
| Earning Date | 12-12-2025 | 12-17-2025 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $29,814,000.00 | N/A |
| Revenue This Year | $2.37 | N/A |
| Revenue Next Year | $4.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.73 | $2.11 |
| 52 Week High | $4.89 | $14.20 |
Technical Indicators
Market Signals| Indicator | ZDGE | VERU |
|---|---|---|
| Relative Strength Index (RSI) | 68.78 | 37.93 |
| Support Level | $2.72 | $2.17 |
| Resistance Level | $4.70 | $2.60 |
| Average True Range (ATR) | 0.37 | 0.17 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 43.44 | 22.64 |
Price Performance
Historical ComparisonAbout ZDGE Zedge Inc. Class B
Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.